COVID-19

Zhiyong Xiao1, Yizhen Guo1, Jingxuan Li1

  • 1Beijing Institute of Pharmacology & Toxicology, Beijing 100850, China; State Key Laboratory of National Security Specially Needed Drug, Beijing Institute of Pharmacology & Toxicology, Beijing 100850, China.

Carbohydrate polymers
|September 8, 2024
PubMed
概括

传统中医药中的多糖体通过阻断病毒的进入和增强训练免疫力,显示出对抗COVID-19的前景. 需要进一步的研究来探索它们对抗SARS-CoV-2的治疗潜力.